The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the patient's heart.

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as ...

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...

Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up ...

Mitral regurgitation is the most common form of valvular heart disease and affects around 10% of Americans over 75. It occurs when the mitral ...

As health care in the United States has shifted from a volume-driven to value-driven system, collection of patient-reported outcome measures has become increasingly important as the data provided ...